Kyodo Pharmaceutical: Indicative Announcement on 2025 Annual Report Disclosure

Securities code: 300966 Securities abbreviation: Gongyong Pharmaceutical Announcement number: 2026-010 Convertible bond code: 123171 Convertible bond abbreviation: Gongyong convertible bonds

Hubei Tongyong Pharmaceutical Co., Ltd.

2025 Annual Report Disclosure Indicative Announcement

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and that there are no false records, misleading statements or major omissions.

Hubei Tongyong Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the 13th meeting of the third board of directors on April 27, 2026, and reviewed and approved the "Proposal on the Company's 2025 Annual Report and its Summary".

In order to enable investors to fully understand the company's operating results, financial status and future development plans, the company's "2025 Annual Report" and its summary were published on the same day on the China Securities Regulatory Commission's GEM information disclosure website Juchao Information Network (www.cninfo.com.cn). Investors are advised to check it out.

Announcement is hereby made.

Hubei Tongyong Pharmaceutical Co., Ltd. Board of Directors

April 28, 2026